According to the cBioPortal cancer genomic database, in a curated set of non-redundant studies, KEAP1 gene mutations are found in around 3% of samples; the highest percentage of KEAP1 mutations is found in lung cancer (13–16%), lung adenocarcinoma (15%), and non-small-cell lung cancer (NSCL, 13%). Here, KEAP1 is linked to lung carcinoma.